Capabilities

The CD3 has an established network of expert resources and capabilities which generally span the entire spectrum from the discovery of fundamental research concepts and initiation of new therapeutic paradigms, all the way to and including the submission of IND activities and related clinical investigations. Any component or mix of components from this network can be brought to bear on problems which may be of interest to the private sector.

For example, besides basic research activities, collaborations could involve specific 'needs analyses' and contract arrangements geared toward advancement of distinct technologies through development stages where a small company might lack sufficient expertise or capability. Likewise, for larger companies having considerable resources already engaged in multi-project scenarios, interactions might involve exploration of high-risk research projects and potential spin-off areas without the need to jeopardize internal corporate resources. Alternatively, broad and specific interactions with either large or small entities might be envisioned to simply tap the intellectual diversity afforded by the CD3 network in order to gain a different perspective at any step during drug design and development.

Return to CD3 Home Page Return to UT Home Page